Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial

INTRODUCTION: The 2019 American Thoracic Society/Infectious Disease Society of America guidelines recommend respiratory fluoroquinolones to treat community-acquired bacterial pneumonia (CABP) in adults with comorbidities. Fluoroquinolones are effective against both typical and atypical pathogens. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, George D., Warren, Nathan, Yashayev, Roman, Chitra, Surya, Amodio-Groton, Maria, Wright, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420047/
https://www.ncbi.nlm.nih.gov/pubmed/37575994
http://dx.doi.org/10.3389/fmed.2023.1225710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420047/
https://www.ncbi.nlm.nih.gov/pubmed/37575994
http://dx.doi.org/10.3389/fmed.2023.1225710

Ejemplares similares